0
POPSDear Dr. Garnier Glaxo gets a warning letter from the FDA, which says the company didn't provide full and timely information about Avandia. "We take these findings seriously, and corrective steps to make sure we file periodic reports completely and promptly have been taken or are underway," said Dr. Ronald Krall, Chief Medical Officer at GlaxoSmithKline said in a prepared statement. "These omissions did not interfere with the timely reporting of adverse event information to the FDA."